Rasagiline Mesylate — CAS 161735-79-1

Rasagiline Mesylate is a high-purity Active Pharmaceutical Ingredient (API) classified under MAO-B Inhibitor / Antiparkinson Agent. Mediocon Inc manufactures GMP-compliant Rasagiline Mesylate at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

• Parkinson's disease (monotherapy & adjunctive therapy with levodopa)
• Selective irreversible MAO-B inhibition
• Prolonging dopamine activity in the brain
• Neuroprotection in substantia nigra

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support